Taken together, the present study identified a new target of miR-301a and confirmed that miR-301a activated the mTOR signaling pathway by negatively regulating TSC1, thus promoting the activation and proliferation of fibroblasts, formation of myofibroblasts, and collagen deposition and eventually leading to pulmonary fibrosis. The gene discussed is TSC1; the disease is pulmonary fibrosis.